Please wait a minute...
浙江大学学报(医学版)  2016, Vol. 45 Issue (4): 356-363    DOI: 10.3785/j.issn.1008-9292.2016.07.05
癌分子医学专题     
zeste基因增强子同源物2抑制剂GSK126对前列腺癌细胞的作用及机制
林伟仁1, 陈亚天2, 曾玲晖2, 应荣彪1, 朱锋2
1. 浙江省台州市肿瘤医院内科, 浙江 温岭 317502;
2. 浙江大学城市学院医学院, 浙江 杭州 310015
Effect of a novel EZH2 inhibitor GSK126 on prostate cancer cells
LIN Weiren1, CHEN Yatian2, ZENG Linghui2, YING Rongbiao1, ZHU Feng2
1. Department of Internal Medicine, Taizhou Cancer Hospital, Wenling 317502, China;
2. School of Medicine, Zhejiang University City College, Hangzhou 310015, China
全文: PDF(1293 KB)  
摘要: 

目的:探究zeste基因增强子同源物2(EZH2)抑制剂GSK126对前列腺癌细胞增殖、凋亡及迁移的作用及机制。方法:以磺酰罗丹明B实验考察GSK126对PC-3和DU145细胞增殖的影响,以Annexin V/PI双染法考察GSK126对细胞凋亡的影响,以Transwell实验和细胞划痕实验观察GSK126对细胞迁移和侵袭的影响,以荧光定量PCR检测GSK126对肿瘤相关基因mRNA表达的影响,以蛋白质印迹法检测相关蛋白水平的变化。结果:GSK126仅在50.0 μmol/L的高浓度剂量时能有效抑制PC-3和DU145细胞增殖,并促进其凋亡。经GSK126小、中、大剂量(5.0、20.0、50.0 μmol/L)处理后,PC-3细胞划痕间距分别为(247.2±24.4)μm、(347.2±19.2)μm、(410.5±18.1)μm,与对照组(171.3±17.8)μm比较差异均有统计学意义(均P<0.05),且呈一定的量效关系。Transwell实验结果显示,每视野下侵袭的PC-3细胞数对照组为322.0±17.9,而经GSK126小、中、大剂量处理后分别为198.3±15.4、82.7±6.2、30.2±4.1,与对照组比较差异均有统计学意义(均P<0.05)。GSK126处理前列腺癌细胞后,与上皮细胞间质转化相关的E-cadherin基因mRNA表达量上升,N-cadherin、Vimentin基因mRNA表达量下降,但Snail、Fibronectin、VEGF-A基因的mRNA表达无变化。同时,蛋白质印迹法检测结果提示,E-cadherin的蛋白表达量增加,而VEGF-A蛋白表达量无明显改变。DU145细胞上述实验结果相似。结论:GSK126能有效抑制PC-3细胞和DU145细胞迁移和侵袭,其机制与抑制上皮细胞间质转化相关。GSK126可作为潜在的前列腺癌临床治疗用药。

关键词 基因,肿瘤抑制/药物作用前列腺肿瘤/药物疗法肿瘤蛋白质类/生物合成蛋白甲基转移酶类细胞运动细胞增殖细胞凋亡细胞系,肿瘤    
Abstract

Objective: To investigate the effect of a novel EZH2 inhibitor GSK126 on cell growth, apoptosis and migration of prostate cancer cells. Methods: Prostate cancer PC-3 and DU145 cells were treated with GSK126 at different doses. Cell growth was detected by sulforhodamine assay. Cell apoptosis was assayed by Annexin V-/PI kit. Transwell chamber and wound healing assays were conducted to detect cell migration. The mRNA level was detected by quantitative PCR, and protein expression was detected by Western blot analysis. Results: GSK126 showed significant effect on cell growth and apoptosis when the dose was higher than 50 μmol/L. Wound healing assay revealed that scratch space in PC-3 cells was significantly increased in a dose-dependent manner in GSK126-treated groups[(247.2±24.4),(347.2±19.2) and (410.5±18.1) μm in low, medium and high dose (5.0, 20.0, 50.0 μmol/L), respectively] as compared with the control group[(171.3±17.8) μm](all P<0.05). Transwell assay showed that migrated PC-3 cells in control group was 322.0±17.9,while those in GSK126-treated groups were 198.3±15.4 (low),82.7±6.2 (medium) and 30.2±4.1 (high), and the differences between the control group and GSK126-treated groups were significant(all P<0.05). In addition, GSK126 up-regulated E-cadherin mRNA expression and down-regulated N-cadherin and Vimentin mRNA expression, whereas had no significant effect on Snail, Fibronectin and VEGF-A mRNA expression. The protein expression of E-cadherin was elevated but VEGF-A protein did not change in GSK126-treated groups. Similar results were exhibited in DU145 cell. Conclusion: GSK126 can significantly inhibit cell migration and invasion in prostate cancer PC-3 and DU145 cells, which may be resulted from its effect on epithelial-mesenchymal transition. GSK126 may be used as a potential anti-prostate cancer dug in clinic.

Key wordsGenes, tumor suppressor/drug effects    Prostatic neoplasms/drug therapy    Neoplasm proteins/biosynthesis    Protein methyltransferases    Cell movement    Cell proliferation    Apoptosis    Cell line, tumor
收稿日期: 2016-02-18
CLC:  R73-3  
基金资助:

浙江省医药卫生科研项目(2015KYA148);浙江省自然科学基金(LY12H16005)

通讯作者: 朱锋(1978-),女,硕士,讲师,主要从事药理学研究;E-mail:zhuf@zucc.edu.cn;http://orcid.org/0000-0002-3220-6762     E-mail: zhuf@zucc.edu.cn
作者简介: 林伟仁(1971-),男,学士,副主任医师,主要从事肿瘤的诊治和研究;E-mail:linweiren1971@163.com;http://orcid.org/0000-0002-0224-5496
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  

引用本文:

林伟仁 等. zeste基因增强子同源物2抑制剂GSK126对前列腺癌细胞的作用及机制[J]. 浙江大学学报(医学版), 2016, 45(4): 356-363.
LIN Weiren, CHEN Yatian, ZENG Linghui, YING Rongbiao, ZHU Feng. Effect of a novel EZH2 inhibitor GSK126 on prostate cancer cells. Journal of ZheJiang University(Medical Science), 2016, 45(4): 356-363.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2016.07.05      或      http://www.zjujournals.com/xueshu/med/CN/Y2016/V45/I4/356

[1] LUNGLMAYR G. Efficacy and tolerability of Casodex in patients with advanced prostate cancer. International Casodex Study Group[J]. Anticancer Drugs, 1995,6(4): 508-513.
[2] SHI Y, LAN F, MATSON C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1[J]. Cell, 2004, 119(7): 941-953.
[3] CHEN Y, YANG Y, WANG F, et al. Crystal structure of human histone lysine-specific demethylase 1(LSD1)[J]. Proc Natl Acad Sci U S A, 2006, 103(38): 13956-13961.
[4] YOU J S, JONES P A. Cancer genetics and epigenetics: two sides of the same coin?[J]. Cancer Cell, 2012, 22(1): 9-20.
[5] SHEN L, CUI J, LIANG S, et al. Update of research on the role of EZH2 in cancer progression[J]. Onco Targets Ther, 2013, 6(2): 321-324.
[6] REN G, BARITAKI S, MARATHE H, et al. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer[J]. Cancer Res, 2012,72(12): 3091-3104.
[7] MCCABE M T, OTT H M, GANJI G, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations[J]. Nature, 2012, 492(7427): 108-112.
[8] SATO T, KANEDA A, TSUJI S, et al. PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer[J]. Sci Rep, 2013, 3(5): 1911.
[9] WU C, JIN X, YANG J, et al. Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer[J]. Oncotarget, 2016, 7(3):3440-3452.
[10] CHEN H, TU S W, HSIEH J T. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer[J]. J Biol Chem, 2005, 280(23): 22437-22444.
[11] CHEN Y T, ZHU F, LIN W R, et al. The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis in via down regulating VEGF-A[J]. Cancer Chemother Pharmacol, 2016, 77(4):757-765.
[12] YU J M, SUN W, HUA F, et al. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells[J]. Cancer Lett, 2015, 365(2): 190-200.
[13] YU J, CAO Q, YU J, et al. The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer[J]. Oncogene, 2010, 29(39): 5370-5380.
[14] Mcgarvey K M, Greene E, Fahrner J A, et al. DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2[J]. Cancer Res, 2007, 67(11): 5097-5102.
[15] 陆虹昊, 马俐君. 上皮间质细胞转化的分子机制及其在肿瘤转移中的作用[J]. 中国肿瘤生物治疗杂志, 2009, 16(5): 541-545. LU Honghao, MA Lijun. The mechanism of epithelial-mesenchymal transition and its effect in tumor metastasis[J]. Chinese Journal of Cancer Biotherapy,2009, 16(5): 541-545. (in Chinese)
[1] 曹鹏 等. 双氢青蒿素抗肿瘤分子生物学机制研究进展[J]. 浙江大学学报(医学版), 2016, 45(5): 501-507.
[2] 陈晓静 等. 微RNA-let-7e-3p在宫颈上皮内瘤变和宫颈癌组织中的表达及临床意义[J]. 浙江大学学报(医学版), 2016, 45(4): 342-348.
[3] 娄鹏荣 等. 靶向RAD18的小干扰RNA对人食管鳞癌ECA-109细胞增殖和化疗敏感性的影响[J]. 浙江大学学报(医学版), 2016, 45(4): 364-370.
[4] 王程 等. 微RNA:一类新的椎间盘退变调控因子[J]. 浙江大学学报(医学版), 2016, 45(2): 170-178.
[5] 徐力等. SN-38与索拉非尼联合应用体外抗肝癌效果及其机制[J]. 浙江大学学报(医学版), 2015, 44(5): 486-492.
[6] 陶泉玮等. 聚腺苷二磷酸核糖聚合酶抑制剂联合卡铂对人乳腺癌细胞凋亡的影响[J]. 浙江大学学报(医学版), 2015, 44(5): 506-510.
[7] 杨敏丽, 叶招明. 极低频电磁场诱导人骨肉瘤细胞凋亡及其机制研究[J]. 浙江大学学报(医学版), 2015, 44(3): 323-328.
[8] 辛廖冰, 江秀秀, 叶小磊, 吴瑞瑾, 徐开红, 马俊彦, 林俊. 稳定沉默水通道蛋白5基因对异位子宫内膜腺上皮细胞增殖及迁移的影响[J]. 浙江大学学报(医学版), 2015, 44(3): 285-292.
[9] 王小军, 张浩, 詹红生, 丁道芳. 应用大鼠血清建立体外软骨细胞退变模型[J]. 浙江大学学报(医学版), 2015, 44(3): 308-314.
[10] 韩艳霞, 尤良顺, 刘辉, 毛莉萍, 叶琇锦, 钱文斌. 细胞周期蛋白依赖激酶抑制剂诱导HL-60细胞凋亡及分子机制研究[J]. 浙江大学学报(医学版), 2015, 44(2): 174-178.
[11] 王浩, 耿赵铭, 胡智伟, 王舒燕, 赵冰. 丹皮酚抑制帕金森病模型细胞凋亡的作用[J]. 浙江大学学报(医学版), 2015, 44(1): 30-36.
[12] 童旭辉, 谷昱琛, 焦浩, 于丽, 董淑英. 抑制细胞间缝隙连接通讯功能对星形胶质细胞缺氧/复氧损伤的保护作用[J]. 浙江大学学报(医学版), 2015, 44(1): 67-73.
[13] 郑永霞,张成文,惠斌,等. 磷脂酰肌醇3激酶调节亚基基因对HepG2细胞增殖的影响[J]. 浙江大学学报(医学版), 2014, 43(5): 559-.
[14] 泮辉,等. 胎盘生长因子恢复急性心肌梗死大鼠心功能及其机制[J]. 浙江大学学报(医学版), 2014, 43(4): 441-447.
[15] 韩晓瑜,章璐,刘志娴,等. 白三烯D4在体外对A549肺泡上皮细胞增殖及迁移的影响[J]. 浙江大学学报(医学版), 2014, 43(3): 287-292.